16:02 Dec 20
Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Eris Lifesciences Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
43/100
Medium Financial Strength
Valuation
23/100
Expensive Valuation
Technical
59/100
Technically Neutral
Strength
5
Weakness
7
Opportunity
0
Threats
0
0.00 %
Dividend Yield
18.79K
Market Cap (Cr)
42.17
RSI
54.87 %
Promoter Holding
19.50 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 11-Aug-2022 | Dividend | 7.35/share@735.00% | 16-Aug-2022 | 735.00 | Interim |
| 05-Aug-2021 | Dividend | 6.01/share@601.00% | 06-Aug-2021 | 601.00 | Interim |
| 13-Aug-2020 | Dividend | 5.50/share@550.00% | 14-Aug-2020 | 550.00 | Interim |
| 19-Mar-2020 | Dividend | 2.87/share@287.00% | 20-Mar-2020 | 287.00 | Interim |
| 12-Jul-2019 | Tender Offer | Ratio | - | - | - |
Download Our App On:
